• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用单价噬菌体展示进行抗体人源化。

Antibody humanization using monovalent phage display.

作者信息

Baca M, Presta L G, O'Connor S J, Wells J A

机构信息

Department of Protein Engineering, Genentech, Inc., South San Francisco, California 94080, USA.

出版信息

J Biol Chem. 1997 Apr 18;272(16):10678-84. doi: 10.1074/jbc.272.16.10678.

DOI:10.1074/jbc.272.16.10678
PMID:9099717
Abstract

Antibody humanization often requires the replacement of key residues in the framework regions with corresponding residues from the parent non-human antibody. These changes are in addition to grafting of the antigen-binding loops. Although guided by molecular modeling, assessment of which framework changes are beneficial to antigen binding usually requires the analysis of many different antibody mutants. Here we describe a phage display method for optimizing the framework of humanized antibodies by random mutagenesis of important framework residues. We have applied this method to humanization of the anti-vascular endothelial growth factor murine monoclonal antibody A4.6.1. Affinity panning of a library of humanized A4.6.1 antibody mutants led to the selection of one variant with greater than 125-fold enhanced affinity for antigen relative to the initial humanized antibody with no framework changes. A single additional mutation gave a further 6-fold improvement in binding. The affinity of this variant, 9.3 nM, was only 6-fold weaker than that of a murine/human chimera of A4.6.1. This method provides a general means of rapidly selecting framework mutations that improve the binding of humanized antibodies to their cognate antigens and may prove an attractive alternative to current methods of framework optimization based on cycles of site-directed mutagenesis.

摘要

抗体人源化通常需要将框架区中的关键残基替换为亲本非人类抗体的相应残基。这些改变是在移植抗原结合环之外的。尽管有分子建模的指导,但评估哪些框架改变对抗原结合有益通常需要分析许多不同的抗体突变体。在此,我们描述了一种通过对重要框架残基进行随机诱变来优化人源化抗体框架的噬菌体展示方法。我们已将此方法应用于抗血管内皮生长因子鼠单克隆抗体A4.6.1的人源化。对人源化A4.6.1抗体突变体文库进行亲和力淘选,相对于未进行框架改变的初始人源化抗体,筛选出了一种对抗原亲和力提高超过125倍的变体。单一的额外突变使结合力进一步提高了6倍。该变体的亲和力为9.3 nM,仅比A4.6.1的鼠/人嵌合体弱6倍。此方法提供了一种快速选择框架突变的通用方法,可改善人源化抗体与其同源抗原的结合,并且可能被证明是基于定点诱变循环的当前框架优化方法的一种有吸引力的替代方法。

相似文献

1
Antibody humanization using monovalent phage display.使用单价噬菌体展示进行抗体人源化。
J Biol Chem. 1997 Apr 18;272(16):10678-84. doi: 10.1074/jbc.272.16.10678.
2
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.一种用于实体瘤及其他病症治疗的抗血管内皮生长因子单克隆抗体的人源化。
Cancer Res. 1997 Oct 15;57(20):4593-9.
3
Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.一种优化抗VEGF抗体的筛选与分析:亲和力成熟的Fab与抗原复合物的晶体结构
J Mol Biol. 1999 Nov 5;293(4):865-81. doi: 10.1006/jmbi.1999.3192.
4
Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display.通过噬菌体展示筛选具有改善的碳水化合物结合能力的抗体单链可变片段。
J Biol Chem. 1994 Apr 1;269(13):9533-8.
5
[Selection and characterization of human antibodies against vascular endothelial growth factor from human phage display antibody library].[从人噬菌体展示抗体库中筛选及鉴定抗血管内皮生长因子的人源抗体]
Zhonghua Yi Xue Za Zhi. 2000 Aug;80(8):567-70.
6
Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.通过同时优化框架区和互补决定区残基对鼠单克隆抗体进行人源化。
J Mol Biol. 1999 Nov 19;294(1):151-62. doi: 10.1006/jmbi.1999.3141.
7
VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.血管内皮生长因子(VEGF)与人源化中和抗体的Fab片段:复合物的2.4埃分辨率晶体结构及界面的突变分析
Structure. 1998 Sep 15;6(9):1153-67. doi: 10.1016/s0969-2126(98)00116-6.
8
Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.构建一种人源化双特异性F(ab')2片段以增强与T细胞的结合。
Int J Cancer Suppl. 1992;7:45-50.
9
Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.通过对接近受体框架的互补决定区残基进行重新设计来实现抗体人源化。
Methods. 2014 Jan 1;65(1):68-76. doi: 10.1016/j.ymeth.2013.06.024. Epub 2013 Jun 28.
10
A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing.两种通过互补决定区移植和可变区表面重塑人源化的小鼠单克隆抗体的比较。
Protein Eng. 1996 Oct;9(10):895-904. doi: 10.1093/protein/9.10.895.

引用本文的文献

1
Development and in vitro characterization of humanized antibodies for blocking human TRPM4 channel.用于阻断人TRPM4通道的人源化抗体的开发及体外特性研究
Sci Rep. 2025 Jun 5;15(1):19769. doi: 10.1038/s41598-025-05256-x.
2
Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization.揭开纳米抗体工程的新篇章:传统构建方法与人工智能驱动优化的进展
J Nanobiotechnology. 2025 Feb 6;23(1):87. doi: 10.1186/s12951-025-03169-5.
3
Prospects for the computational humanization of antibodies and nanobodies.
抗体和纳米抗体计算人源化的前景。
Front Immunol. 2024 May 15;15:1399438. doi: 10.3389/fimmu.2024.1399438. eCollection 2024.
4
Advancement in the development of single chain antibodies using phage display technology.利用噬菌体展示技术开发单链抗体的进展。
PeerJ. 2024 Apr 10;12:e17143. doi: 10.7717/peerj.17143. eCollection 2024.
5
The immunogenicity of human-origin therapeutic antibodies are associated with V gene usage.人源治疗性抗体的免疫原性与 V 基因的使用有关。
Front Immunol. 2023 Sep 1;14:1237754. doi: 10.3389/fimmu.2023.1237754. eCollection 2023.
6
Computational optimization of antibody humanness and stability by systematic energy-based ranking.通过系统的基于能量的排序来计算优化抗体的人源化和稳定性。
Nat Biomed Eng. 2024 Jan;8(1):30-44. doi: 10.1038/s41551-023-01079-1. Epub 2023 Aug 7.
7
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions.具有不同表位特异性和 Fc 效应功能的交叉反应性冠状病毒抗体。
Cell Rep Med. 2021 Jun 15;2(6):100313. doi: 10.1016/j.xcrm.2021.100313. Epub 2021 May 21.
8
Adaption of human antibody λ and κ light chain architectures to CDR repertoires.人抗体 λ 和 κ 轻链结构的 CDR 文库适应性改造。
Protein Eng Des Sel. 2019 Dec 13;32(3):109-127. doi: 10.1093/protein/gzz012.
9
Engineering Antibodies for the Treatment of Infectious Diseases.工程抗体治疗传染病。
Adv Exp Med Biol. 2017;1053:207-220. doi: 10.1007/978-3-319-72077-7_10.
10
DNA-encoded chemistry: enabling the deeper sampling of chemical space.DNA 编码化学:实现更深入的化学空间采样。
Nat Rev Drug Discov. 2017 Feb;16(2):131-147. doi: 10.1038/nrd.2016.213. Epub 2016 Dec 9.